DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steve Hoerter on Q3 2020 Results - Earnings Call Transcript
Deciphera Pharmaceuticals, Inc. (DCPH) Q3 2020 Earnings Conference Call November 05, 2020, 04:30 PM ET Company Participants Jen Robinson - VP, IR Steve Hoerter - President and CEO Dan Martin - CCO Matt Sherman - CMO Tucker Kelly - CFO Conference Call Participants Jessica Fye - JP Morgan Allison Bratzel - Piper Sandler Eun Yang - Jefferies Charles Zhu - Guggenheim Reni Benjamin - JMP securities Ben Shim - Canaccord Presentation Operator Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. At this time all lines are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's call is being recorded. [Operator Instructions] At this time, I would now like to turn the call over to Jen Robinson, Vice President, Investor Relations. Jen? Jen Robinson Thank you, operator. Welcome, and thank you
For further details see:
Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q3 2020 Results - Earnings Call Transcript